LINDSAY CONGER: Open Payments
NPI 1508346099 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,665 in 83 payments from 14 companies in 2025. Trend: 2023 $958 · 2024 $966 · 2025 $1,665
Food & beverage: $1,665
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $215 |
| Supernus Pharmaceuticals, Inc. | 7 | $183 |
| ABBVIE INC. | 17 | $172 |
| Corium, LLC | 6 | $160 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $150 |
| Alkermes, Inc. | 5 | $120 |
| Teva Pharmaceuticals USA, Inc. | 5 | $111 |
| Janssen Pharmaceuticals, Inc | 5 | $110 |
| Collegium Pharmaceutical, Inc. | 5 | $108 |
| Vanda Pharmaceuticals Inc. | 3 | $104 |
Products named: REXULTI, Qelbree, VRAYLAR, Azstarys, CAPLYTA, LYBALVI, Jornay PM, FANAPT.
Industry payments across TN — which companies pay providers there.
